Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

F8 and F9 mutations in US haemophilia patients: correlation with history of inhibitor and race/ethnicity.

Haemophilia : the official journal of the World Federation of Hemophilia - 1 May 2012

Miller C H, Benson J, Ellingsen D, Driggers J, Payne A, Kelly F M, Soucie J M, Craig Hooper W

Abstract excerpt

Both genetic and treatment-related risk factors contribute to the development of inhibitors in haemophilia. An inhibitor surveillance system piloted at 12 US sites has the goal of assessing risk factors through prospective data collection. This report examines the relationship of genotype and rac...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoantibodies
Share to Blood Coagulation Factor Inhibitors
Share to Factor IX

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Factor VIII

Share to Hemophilia A

Share to Hemophilia B

Share to Introns

Share to United States

Source

Identifiers

PMID: 22103590
DOI: 10.1111/j.1365-2516.2011.02700.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22103590-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

F8 and F9 mutations in US haemophilia patients: correlation with history of inhibitor and race/ethnicity.PMID 22103590Read ↗

Race, ethnicity, F8 variants, and inhibitor risk: analysis of the "My Life Our Future" hemophilia A database.Semantic proximity Read ↗

Human leukocyte antigen alleles associated with inhibitor development in severe hemophilia A: analysis of the "My Life, Our Future" hemophilia A cohort.Semantic proximity Read ↗

Results of genetic analysis of 11 341 participants enrolled in the My Life, Our Future hemophilia genotyping initiative in the United States.Semantic proximity Read ↗

HLA Variants and Inhibitor Development in Hemophilia A: A Retrospective Case-Controlled Study Using the ATHNdatasetSemantic proximity Read ↗

F8/F9 variants in the population-based PedNet Registry cohort compared with locus-specific genetic databases of the European Association for Haemophilia and Allied Disorders and the Centers for Disease Control and Prevention Hemophilia A or Hemophilia B Mutation ProjectSemantic proximity Read ↗

Genetic factors influencing inhibitor development in a cohort of South African haemophilia A patients.Semantic proximity Read ↗

Variant analysis of F8 in 123 patients with hemophilia A: Identification of 18 novel variants.Semantic proximity Read ↗

Relationship between mutations in severe hemophilia A and risk of inhibitor development: A large single-center study.Semantic proximity Read ↗

F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis.Semantic proximity Read ↗

Factor VIII mutations and inhibitor formation in a southern Brazilian population.Semantic proximity Read ↗

Mutation analysis of a cohort of US patients with hemophilia B.Semantic proximity Read ↗

Genomic alterations in the F8 gene correlating with severe hemophilia A in Egyptian patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.